Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
100%
Acute Myeloid Leukemia
70%
Receptor, Fibroblast Growth Factor, Type 1
55%
Antibodies
49%
Myeloid Progenitor Cells
48%
Myeloid Cells
45%
Gene Fusion
43%
Heterografts
36%
Oncogene Fusion
34%
Protein-Tyrosine Kinases
32%
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
30%
Stem Cells
29%
ponatinib
27%
Fetal Blood
27%
nucleophosmin
24%
Hematopoietic Stem Cells
24%
STAT5 Transcription Factor
24%
Interleukin-1
23%
Disease Progression
23%
Dasatinib
23%
Interleukin-1 Receptors
22%
Complement Receptors
22%
Myeloproliferative Disorders
21%
Cytokines
20%
Blood Cells
20%
B-Lymphoid Precursor Cells
20%
Imatinib Mesylate
19%
Transcriptome
17%
Mast Cells
16%
Therapeutics
16%
Erythroid Cells
15%
Therapeutic Uses
15%
Bone Marrow Cells
15%
Genes
14%
Neoplasms
13%
Leukemia
13%
Chromosomes, Human, Pair 9
12%
Blast Crisis
10%
Clone Cells
10%
Haploinsufficiency
10%
Apoptosis
10%
Exons
9%
Proteins
9%
Cell Differentiation
9%
Interleukin-1 Receptor Accessory Protein
8%
Transplantation
8%
Leukemia, Myeloid, Chronic Phase
7%
Chromosomes, Human, Pair 22
7%
Cell Proliferation
7%
Bone Marrow
6%